Does fisetin clear senescent cells in people?

We don't know yet whether fisetin clears senescent cells in people. Cleared cells have been shown only in cells and mice, and no human trial has shown it.

Who it's for

No group has a proven benefit; it remains a research compound.

What to expect

No clear benefit shown in people; effects on senescent cells are unproven.

Watch out for

Human safety data are thin, with small and short trials.

What the studies show

• Fisetin's cell-killing effect on senescent cells was first found in a screen of plant compounds in senescent human and mouse skin-type cells (fibroblasts)4Review · 2026Targeting cellular senescence through nutritional senotherapeutics in brain aging and neurodegenerative diseases.Current evidence from experimental models and emerging clinical studies suggests that nutritional senotherapeutics represent promising complementary strategies for modulating cellular senescence and promoting brain health. However, their clinical translation remains constrained by limited human evidence, low…Front Nutr. Later lab work reported fewer senescent cells of several types in the fat tissue of mice4Review · 2026Targeting cellular senescence through nutritional senotherapeutics in brain aging and neurodegenerative diseases.Current evidence from experimental models and emerging clinical studies suggests that nutritional senotherapeutics represent promising complementary strategies for modulating cellular senescence and promoting brain health. However, their clinical translation remains constrained by limited human evidence, low…Front Nutr.
• In old mice given fisetin in cycles (1 week on, 2 weeks off, 1 week on), frailty scores and grip strength improved compared with untreated mice of the same age. Signs of senescence in muscle also fell3Review · 2026Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A.Together, the four compounds primarily target distinct but complementary aging-associated pathways (autophagy, senolysis, metabolic regulation, mitophagy), suggesting rational potential for combined functional food formulations. Limited direct evidence for their combined use and the need for dedicated…Nutrients. The improvement was reported as similar to that from genetic removal of senescent cells and from a drug, ABT-2633Review · 2026Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A.Together, the four compounds primarily target distinct but complementary aging-associated pathways (autophagy, senolysis, metabolic regulation, mitophagy), suggesting rational potential for combined functional food formulations. Limited direct evidence for their combined use and the need for dedicated…Nutrients.
• A review of 34 registered fisetin trials looked closely at the 4 completed trials with results. It called the human evidence limited and mixed. Some trials showed better metabolic or inflammation measures, and others showed no clear benefit2Review · 2026Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities.Interpretation is further limited by small sample sizes, multimodal interventions, and uncontrolled or exploratory designs, making it difficult to establish fisetin efficacy in humans. Early findings in animal models and in human cell lines suggest that fisetin has the potential to mitigate age-related diseases by…Nutrients. The trials were small, often tested fisetin alongside other treatments, and were uncontrolled or exploratory2Review · 2026Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities.Interpretation is further limited by small sample sizes, multimodal interventions, and uncontrolled or exploratory designs, making it difficult to establish fisetin efficacy in humans. Early findings in animal models and in human cell lines suggest that fisetin has the potential to mitigate age-related diseases by…Nutrients.
• A systematic reviewsystematic review A review that searches for every study on a question in a set way and weighs them together, rather than picking a few. of 6 completed human trials of drugs targeting senescent cells found early signs of fewer senescence markers, mostly with dasatinib plus quercetin. It did not single out fisetin. It concluded the evidence cannot establish that these treatments work or are safe long term1Systematic review · 2026Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials.Senolytic and senomorphic strategies should therefore be considered investigational rather than established therapies. Larger, adequately powered randomized trials with standardized senescence biomarkers, clinically meaningful outcomes, longer follow-up and systematic safety assessment are needed.Br J Clin Pharmacol.
• A scoping review of 111 lab and animal studies of plant compounds found many act on pathways that can push senescent cells to die. Its authors noted that methods for inducing and measuring senescence differ widely between studies5Animal study · 2026Plant-Derived Senotherapeutics in Cellular Senescence: A Scoping Review of Preclinical Evidence, Mechanistic Pathways, and Metabolomic-Guided Discovery.However, challenges in pharmacokinetic optimization, methodological heterogeneity in senescence induction and biomarker panels persist. Plant-derived senotherapy characterized through metabolomics-guided pipelines provides a compelling foundation for their progression toward clinical validation and functional food…Int J Mol Sci.

Key studies

Safety

Reported side effects in senescence-targeting trials overall were mostly mild or manageable. Small size and short follow-up mean rare or long-term harms are unknown1Systematic review · 2026Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials.Senolytic and senomorphic strategies should therefore be considered investigational rather than established therapies. Larger, adequately powered randomized trials with standardized senescence biomarkers, clinically meaningful outcomes, longer follow-up and systematic safety assessment are needed.Br J Clin Pharmacol. Doses that work, and how much fisetin reaches tissues such as the brain, are unresolved4Review · 2026Targeting cellular senescence through nutritional senotherapeutics in brain aging and neurodegenerative diseases.Current evidence from experimental models and emerging clinical studies suggests that nutritional senotherapeutics represent promising complementary strategies for modulating cellular senescence and promoting brain health. However, their clinical translation remains constrained by limited human evidence, low…Front Nutr.

What we don't know

• Whether fisetin removes senescent cells in human tissue, since no trial has measured this convincingly2Review · 2026Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities.Interpretation is further limited by small sample sizes, multimodal interventions, and uncontrolled or exploratory designs, making it difficult to establish fisetin efficacy in humans. Early findings in animal models and in human cell lines suggest that fisetin has the potential to mitigate age-related diseases by…Nutrients.
• Which dose and schedule, if any, would be effective and safe in people4Review · 2026Targeting cellular senescence through nutritional senotherapeutics in brain aging and neurodegenerative diseases.Current evidence from experimental models and emerging clinical studies suggests that nutritional senotherapeutics represent promising complementary strategies for modulating cellular senescence and promoting brain health. However, their clinical translation remains constrained by limited human evidence, low…Front Nutr.